Cargando…
Clinical relevance of cancer stem cell chemotherapeutic assay for recurrent ovarian cancer()
INTRODUCTION: Disease recurrence and progression of ovarian cancer is common with the development of platinum-resistant or refractory disease. This is due in large part to the presence of chemo-resistant cancer stem cells (CSCs) that contribute to tumor propagation, maintenance, and treatment resist...
Autores principales: | Howard, Candace M., Zgheib, Nadim Bou, Bush, Stephen, DeEulis, Timothy, Cortese, Antonio, Mollo, Antonio, Lirette, Seth T., Denning, Krista, Valluri, Jagan, Claudio, Pier Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475270/ https://www.ncbi.nlm.nih.gov/pubmed/32862103 http://dx.doi.org/10.1016/j.tranon.2020.100860 |
Ejemplares similares
-
Cancer Stem Cell Assay for the Treatment of Platinum-Resistant Recurrent Ovarian Cancer
por: Howard, Candace M, et al.
Publicado: (2021) -
Treatment of unmethylated MGMT-promoter recurrent glioblastoma with cancer stem cell assay-guided chemotherapy and the impact on patients’ healthcare costs
por: Ranjan, Tulika, et al.
Publicado: (2023) -
Cancer Stem Cell Chemotherapeutics Assay for Prospective Treatment of Recurrent Glioblastoma and Progressive Anaplastic Glioma: A Single-Institution Case Series()
por: Ranjan, Tulika, et al.
Publicado: (2020) -
Analysis of Chemopredictive Assay for Targeting Cancer Stem Cells in Glioblastoma Patients
por: Howard, Candace M., et al.
Publicado: (2017) -
Rapid Selection and Proliferation of CD133(+) Cells from Cancer Cell Lines: Chemotherapeutic Implications
por: Kelly, Sarah E., et al.
Publicado: (2010)